# FNB Corp: overview

FNB · NYSE · CIK 37808 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fnb.md) · [Financials](/companies/fnb/financials.md) · [Filings](/companies/fnb/filings.md) · [Insiders](/companies/fnb/insiders.md)

Revenue is not reported in this company’s XBRL financial statements.

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | [0.30](/filings/0000037808-25-000135.md) | not reported | [0.32](/filings/0000037808-26-000011.md) | [0.36](/filings/0000037808-26-000025.md) | [0.41](/filings/0000037808-25-000135.md) | not reported | [0.38](/filings/0000037808-26-000011.md) | [0.42](/filings/0000037808-26-000025.md) |
| Free cash flow | $m | [(46.0) d](/filings/0000037808-25-000135.md) | [278 d](/filings/0000037808-26-000007.md) | [43.0](/filings/0000037808-26-000011.md) | [85.0 d](/filings/0000037808-26-000025.md) | [149 d](/filings/0000037808-25-000135.md) | [99.0 d](/filings/0000037808-26-000007.md) | [133](/filings/0000037808-26-000011.md) | [241 d](/filings/0000037808-26-000025.md) |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | [1.23](/filings/0000037808-24-000006.md) | [1.22](/filings/0000037808-25-000071.md) | [1.31](/filings/0000037808-26-000007.md) | [1.27](/filings/0000037808-26-000007.md) | [1.56](/filings/0000037808-26-000007.md) |
| Free cash flow | $m | [472](/filings/0000037808-24-000006.md) | [1,123](/filings/0000037808-25-000071.md) | [335](/filings/0000037808-26-000007.md) | [503](/filings/0000037808-26-000007.md) | [376](/filings/0000037808-26-000007.md) |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/fnb/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $891.4m | 46,720,806 |  | Added +2,139,265 |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $510.5m | 26,757,771 |  | Added +2,799,991 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $383.5m | 20,099,642 |  | Added +227,130 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $382.5m | 20,044,699 |  | Added +368,278 |
| [FULLER & THALER ASSET MANAGEMENT, INC.](/funds/1082327.md) | 2026-06-30 | $318.8m | 16,708,254 |  | Reduced −1,159,346 |
| [FIRST TRUST ADVISORS LP](/funds/1125816.md) | 2026-06-30 | $310.7m | 16,284,370 |  | Added +5,305,735 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $307.7m | 16,127,538 |  | Added +108,844 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $300.9m | 15,770,476 |  | Added +354,981 |
| [AQR CAPITAL MANAGEMENT LLC](/funds/1167557.md) | 2026-06-30 | $197.3m | 10,342,210 |  | Added +7,099,927 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $125.4m | 6,569,168 |  | Reduced −10,865 |

## Recent filings

[All 2,163 filings](/companies/fnb/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-20 | 07:30 ET | [8-K](/filings/0000037808-26-000027.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000037808-26-000027 |
| 2026-08-05 | 12:15 ET | [10-Q](/filings/0000037808-26-000025.md) | Quarterly report, period 2026-06-30 | 0000037808-26-000025 |
| 2026-07-17 | 07:34 ET | [8-K](/filings/0000037808-26-000023.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000037808-26-000023 |
| 2026-05-19 | 16:08 ET | [8-K](/filings/0000037808-26-000017.md) | 5.02 Departure or appointment of officers or directors | 0000037808-26-000017 |
| 2026-05-08 | 09:00 ET | [8-K](/filings/0000037808-26-000014.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0000037808-26-000014 |
| 2026-05-06 | 14:38 ET | [10-Q](/filings/0000037808-26-000011.md) | Quarterly report, period 2026-03-31 | 0000037808-26-000011 |
| 2026-04-17 | 07:37 ET | [8-K](/filings/0000037808-26-000009.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000037808-26-000009 |
| 2026-04-14 | 17:27 ET | [8-K](/filings/0001552781-26-000246.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001552781-26-000246 |
| 2026-03-25 | 09:00 ET | [DEF 14A](/filings/0001193125-26-122941.md) | Proxy statement, period 2026-05-06 | 0001193125-26-122941 |
| 2026-02-24 | 17:20 ET | [10-K](/filings/0000037808-26-000007.md) | Annual report, period 2025-12-31 | 0000037808-26-000007 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0000037808-26-000007.md), filed Feb 24, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 37808
- Tickers: FNB
- Exchange: NYSE
- SIC code: 6021 National Commercial Banks
- State of incorporation: PA
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 10:09 ET. No prices; not investment advice.